OptiNose, Inc. - Common Stock (OPTN)
9.1700
+0.00 (0.00%)
Optinose Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapeutic solutions for patients suffering from sinus and allergy-related conditions
The company's primary product utilizes its proprietary drug delivery technology to administer medications directly to the nasal cavity, aimed at improving the treatment efficacy for various disorders, including chronic rhinosinusitis and allergic rhinitis. Through its commitment to research and development, Optinose strives to enhance patient outcomes and quality of life by delivering effective, non-invasive treatment options.
Frequently Asked Questions
Is OptiNose, Inc. - Common Stock publicly traded?
Yes, OptiNose, Inc. - Common Stock is publicly traded.
What exchange does OptiNose, Inc. - Common Stock trade on?
OptiNose, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OptiNose, Inc. - Common Stock?
The ticker symbol for OptiNose, Inc. - Common Stock is OPTN on the Nasdaq Stock Market
What is the current price of OptiNose, Inc. - Common Stock?
The current price of OptiNose, Inc. - Common Stock is 9.170
When was OptiNose, Inc. - Common Stock last traded?
The last trade of OptiNose, Inc. - Common Stock was at 4:00 pm EDT on March 25th, 2025
What is the market capitalization of OptiNose, Inc. - Common Stock?
The market capitalization of OptiNose, Inc. - Common Stock is 488.84M
How many shares of OptiNose, Inc. - Common Stock are outstanding?
OptiNose, Inc. - Common Stock has 53.31M shares outstanding.